Prednisolone/Zoledronic Acid Hydrate

泼尼松龙/唑来膦酸

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePrednisolone/Zoledronic Acid Hydrate
Drug Alias NameZoledronic Acid Hydrate/Prednisolone唑来膦酸/泼尼松龙Prednisolone/Zoledronic AcidVOLT-01
ClassificationSmall molecules > Steroids
Mechanisms of ActionFarnesyl diphosphate synthase inhibitorsBone resorption factor inhibitorsGlucocorticoid receptor agonists
TargetsGlucocorticoid receptorBone resorption factorFarnesyl diphosphate synthase
Therapy Area/IndicationsOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes PrednisoloneZoledronic Acid Hydrate
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesLevolta Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesLevolta PharmaceuticalsTabuk Pharmaceutical Manufacturing Co
Inactive CompaniesN/A
Active IndicationsOsteoarthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A